NovAliX

France
Illkirch-Graffenstaden, Grand Est, France, 67405

Company profile

NovAliX company profile

NovAliX is focusing on the development of enabling chemistry and biophysical technologies to support the pharmaceutical industry's outsourcing needs from discovery to manufacturing. With proprietary SPR technology, X-ray protein crystallography, supramolecular mass spectrometry and chemistry, NovAliX offers comprehensive integrated services for small molecule drug discovery. With advanced NMR technologies, NovAliX provides fine characterization of biologics, thorough analysis of APIs and polymorphism studies to support pharmaceutical development and manufacturing teams.

Business identity

Contact email
[email protected]
Phone number
+33 0 368 330 200
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$1M-$10M
Founded
2002-01-01, Year

Headquarters

Postal code
67405
Country code
FR
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
2
Total equity funding
$2.4M
Last funding
Corporate Round / 2024-08-07
Last equity funding
Corporate Round
Investors
3
Lead investors
1
Founders
3
Articles
19

Founders and investors

Founders

Dino MorasJean-Paul RenaudStephan Jenn

Lead investors

Bruker

Investors

BpifranceBrukerRégion Grand Est